Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Bolt Biotherapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −1 vs. Q1 2023
- Shares held
- 25.1M
- +1.77M (+7.6%) vs. Q1 2023
- Total value
- $32.1M
- −$320.5K (−1.0%) vs. Q1 2023
- New holders
- 4
- 9 more added
- Sold out
- 5
- 10 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BOLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $2.31M |
| Q1 2026 | 24 | $2.49M |
| Q4 2025 | 21 | $3.30M |
| Q3 2025 | 24 | $4.28M |
| Q2 2025 | 25 | $5.10M |
| Q1 2025 | 30 | $7.33M |
| Q4 2024 | 38 | $9.99M |
| Q3 2024 | 32 | $12.2M |
| Q2 2024 | 37 | $17.0M |
| Q1 2024 | 39 | $33.6M |
| Q4 2023 | 40 | $27.0M |
| Q3 2023 | 35 | $25.5M |
| Q2 2023 | 40 | $32.1M |
| Q1 2023 | 41 | $32.4M |
| Q4 2022 | 44 | $26.8M |
| Q3 2022 | 56 | $39.7M |
| Q2 2022 | 62 | $54.8M |
| Q1 2022 | 66 | $79.3M |
| Q4 2021 | 62 | $164.6M |
| Q3 2021 | 72 | $449.1M |
| Q2 2021 | 61 | $513.8M |
| Q1 2021 | 70 | $1.04B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Bolt Biotherapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 3,871,291 | $4.96M | 0.59% | 00.0% | Unchanged |
| Tang Capital Management LLC | 3,333,803 | $4.27M | 0.63% | +1,706,250+104.8% | Added |
| Citadel Advisors LLC | 2,986,147 | $3.82M | 0.00% | +147,702+5.2% | Added |
| Sofinnova Investments, Inc. | 2,754,437 | $3.53M | 0.23% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $2.42M | 0.80% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 1,541,000 | $1.97M | 0.04% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 1,166,952 | $1.49M | 0.95% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 1,049,153 | $1.34M | 0.24% | 00.0% | Unchanged |
| Newtyn Management, LLC | 1,000,000 | $1.28M | 0.30% | −115,110−10.3% | Reduced |
| Vanguard Group Inc | 928,276 | $1.19M | 0.00% | 00.0% | Unchanged |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $921.0K | 0.09% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 500,000 | $640.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 483,939 | $619.0K | 0.00% | +27,200+6.0% | Added |
| Acuitas Investments, LLC | 460,385 | $589.3K | 0.34% | +460,385 | New |
| Hawkeye Capital Management, LLC | 415,039 | $531.3K | 1.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 352,219 | $450.8K | 0.00% | +174,227+97.9% | Added |
| BlackRock Inc. | 287,891 | $368.5K | 0.00% | +13,461+4.9% | Added |
| Goldman Sachs Group Inc | 284,170 | $363.7K | 0.00% | +1,085+0.4% | Added |
| Assenagon Asset Management S.A. | 158,289 | $202.6K | 0.00% | −67,527−29.9% | Reduced |
| JPMorgan Chase & Co | 128,646 | $164.7K | 0.00% | −60,660−32.0% | Reduced |
| Privium Fund Management (UK) Ltd | 116,516 | $148.0K | 0.12% | 00.0% | Unchanged |
| Millennium Management LLC | 113,989 | $145.9K | 0.00% | −131,422−53.6% | Reduced |
| Bridgeway Capital Management, LLC | 101,200 | $129.5K | 0.00% | +26,000+34.6% | Added |
| Marquette Asset Management, LLC | 97,835 | $125.2K | 0.03% | 00.0% | Unchanged |
| FMR LLC | 79,196 | $101.4K | 0.00% | +763+1.0% | Added |
| Squarepoint Ops LLC | 64,013 | $81.9K | 0.00% | +64,013 | New |
| State Street Corp | 48,737 | $62.4K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 33,569 | $43.0K | 0.00% | −272,833−89.0% | Reduced |
| Northern Trust Corp | 31,182 | $39.9K | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 24,400 | $31.2K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 13,309 | $17.0K | 0.00% | +13,309 | New |
| Bank of New York Mellon Corp | 12,578 | $16.1K | 0.00% | −51−0.4% | Reduced |
| Stifel Financial Corp | 12,264 | $15.7K | 0.00% | +12,264 | New |
| Federated Hermes, Inc. | 3,274 | $4.19K | 0.00% | −465−12.4% | Reduced |
| Tower Research Capital LLC (TRC) | 652 | $835 | 0.00% | −3,320−83.6% | Reduced |
| Bank of America Corp | 628 | $804 | 0.00% | −11,152−94.7% | Reduced |
| Northwestern Mutual Wealth Management Co | 400 | $512 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 158 | $202 | 0.00% | +7+4.6% | Added |
| Barclays PLC | 139 | $178 | 0.00% | −8−5.4% | Reduced |
| Salem Investment Counselors Inc | 40 | $52 | 0.00% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −140,000−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −28,500−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −24,712−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −20,120−100.0% | Sold out |